News
Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes
31 May 24
Biotech, Large Cap, News, Health Care, Legal, Top Stories, General
Performance Comparison: Eli Lilly and Co And Competitors In Pharmaceuticals Industry
31 May 24
News, Markets, Trading Ideas
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
30 May 24
Biotech, Long Ideas, Specialty ETFs, Top Stories, Trading Ideas, ETFs, General
Should You Invest in the iShares U.S. Healthcare ETF?
30 May 24
News, Sector ETFs, Markets, Analyst Ratings, Trading Ideas, ETFs
Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs
30 May 24
Analyst Color, News, Price Target, Reiteration, Top Stories, Analyst Ratings, Trading Ideas
Carl Quintanilla Posted On X "GOLDMAN: "We update our market model for Obesity therapeutics and now forecast total worldwide sales of .. $130B in 2030, an increase from our prior $100B forecast. .. For $LLY, we now forecast revenues for the company's AOM portfolio .. in 2024/2027/2030 at $5.3B, $27.6B and $56.6B, representing an increase from $4.7B, $28.2B and $49.7B prior.; Ups target to $785 (prior $740)"
30 May 24
News, Analyst Ratings, Trading Ideas
Urban Outfitters, Eli Lilly And 2 Other Stocks Insiders Are Selling
30 May 24
News, Short Ideas, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
29 May 24
Biotech, Equities, Fintech, Large Cap, Market Summary, Mid Cap, Health Care, Small Cap, Top Stories, Tech
FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
29 May 24
Biotech, Large Cap, News, Health Care, FDA, Top Stories, General
Jim Cramer Recommends Buying Apple, Finds This Tech Stock 'Very Interesting'
29 May 24
Long Ideas, News, Top Stories, Markets, Media, Trading Ideas
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
29 May 24
Equities, News, Health Care, Global, Markets
10 Health Care Stocks With Whale Alerts In Today's Session
28 May 24
Options
Nvidia's Meteoric Rise: How Does It Compare To Other Market Rallies?
28 May 24
Equities, Large Cap
'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches
28 May 24
Biotech, Equities, News, Health Care, Markets, General
Chinese Scientists Achieve World's First Diabetes Cure Using Cell Therapy: Report
27 May 24
News, Health Care, Global
Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford
25 May 24
News, Health Care
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
24 May 24
Biotech, Large Cap, News, Health Care, Top Stories, General
10 Health Care Stocks With Whale Alerts In Today's Session
24 May 24
Options
Jim Cramer Says This Basic Materials Stock Is 'Too Dicey,' Shares His Take On Arista Networks
24 May 24
Long Ideas, News, Top Stories, Markets, Media, Trading Ideas
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
23 May 24
Entertainment
Press releases
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
1 Jun 24
Press Releases
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases
29 May 24
Press Releases
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
29 May 24
News, Press Releases
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
28 May 24
Press Releases
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
24 May 24
Press Releases
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
24 May 24
Press Releases
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
23 May 24
Press Releases
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure
21 May 24
Press Releases
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
21 May 24
News, Press Releases
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries
17 May 24
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
16 May 24
Press Releases
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
8 May 24
News, Press Releases
Lilly Declares Second-Quarter 2024 Dividend
6 May 24
Dividends, Press Releases
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
30 Apr 24
Earnings, Press Releases
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
22 Apr 24
News, Press Releases
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
19 Apr 24
News, Press Releases
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
18 Apr 24
News, Press Releases
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
17 Apr 24
Press Releases
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
16 Apr 24
Press Releases
Thinking about trading options or stock in Intuit, Pinterest, Adobe, Eli Lilly, or Robinhood Markets?
14 Mar 24
Opinion, Press Releases